Effects of Progressive Muscle Relaxation and Mindfulness Meditation in Patients With Chronic Obstructive Pulmonary Disease
- Conditions
- MediationFatigueSymptoms and SignsCOPD
- Registration Number
- NCT04301700
- Lead Sponsor
- Hacettepe University
- Brief Summary
Patients with COPD will be entered. Participants will be randomized to one of three study arms: Arm 1: meditation; Arm 2: relaxation; Arm 3: Control. Hypothesis: Progressive muscle relaxation and mindfulness meditation will decrease severity of dyspnea, fatigue and care dependency.
- Detailed Description
Previous reports have revealed that progressive muscle relaxation and meditation are decreasing symptoms burden in chronic disease. On the other hand, no study has been conducted to determine the effects of progressive relaxation exercise and mindfulness meditation on dyspnea, fatigue and care dependency in patients with COPD. The present study investigates the effects of progressive muscle relaxation and mindfulness meditation in a single-site, 3-arm, assessor-blinded randomized, controlled study of 65 COPD patients. Arm 1: meditation; Arm 2: relaxation; Arm 3: Control.The investigators hypothesize that Progressive muscle relaxation and mindfulness meditation will decrease the severity of dyspnea, fatigue and care dependency.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 65
- older than 40 years
- diagnosed with stage III-IV COPD
- had at least primary school degree
- had no cognitive dysfunction, or communication problems
- were residing in Ankara.
- history of cognitive dysfunction, or communication problems
- illiteracy
- applying any complementary and integrative approach during the study
- participating in a pulmonary rehabilitation program during the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in care dependency Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions Quality of live will be measured by Care Dependency Scale (CDS). The sum of the scores changes from 17 to 85, with higher scores demonstrating lower dependence.
Change in fatigue Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions Quality of live will be measured by Asthma Fatigue Scale (CAFS). The CAFS scores is standardized to 0-100 in line with the following formula, (100 × (total score-minimum value to be obtained)/range), with higher scores indicating greater fatigue.
Change in dyspnea Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions Dyspnea will be measured by The Dyspnea-12 Scale. The range of total score was from 0 to 36, with higher scores demonstrating higher dyspnea level.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hacettepe University
🇹🇷Ankara, Altindag, Turkey
Hacettepe University🇹🇷Ankara, Altindag, Turkey